Across studies, the rate of sudden death in ibrutinib-treated patients ranged from 0.49 to 0.788 per 100 patient-years, roughly double that seen in comparators. In contrast, pooled analyses of ...
In the European Union (EU) Member States, QDENGA is indicated for the prevention of dengue disease in individuals from four years of age and should be administered subcutaneously as a 0.5 mL dose at a ...
Objectives Firefighters face a range of hazards, including strenuous tasks in high-temperature environments and exposure to ...
06/17/2025 Motion to expedite consideration of the petition for a writ of certiorari before judgment filed by petitioners Learning Resources, Inc., et al. 06/18/2025 Response to motion from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback